Work

Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.2_suppl.436

Authors: Arjun Vasant Balar, Gopa Iyer, Matthew I. Milowsky, William C. Huang, Michael Woods, S. Machele Donat, Harry W. Herr, Guido Dalbagni, Bernard H. Bochner, Irina Ostrovnaya, Hikmat Al-Ahmadie, Tracy Lynn Rose, Jamie Cathleen Riches, Brooke Elizabeth Kania, Ashley Marie Regazzi, Asia S. McCoy, Daniela Delbeau, Jonathan E. Rosenberg, Dean F. Bajorin

Institutions: NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Memorial Sloan Kettering Cancer Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, St. Luke's-Roosevelt Hospital Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591527811

Cites:

Cited by: 7

Related to: 10